Each one of us, wherever we may live in the world, at some point in our lives, will take medications to prevent or treat illness. Medications sometimes, though, can provoke serious harm if stored, prescribed, dispensed or administered incorrectly or if monitored insufficiently.
Indeed, medication harm accounts for 50% of the overall preventable harm in medical care. The World Health Organization (WHO) also estimates that 42 billion US dollars of global total health expenditure worldwide can be avoided if medication errors are prevented.
Acknowledging this substantial burden and recognizing the complexity of medication-related harm prevention and reduction, the theme of World Patient Safety Day 2022, marked annually on September 17, is “Medication Safety”.
The 2022 Campaign:
The global campaign reaffirms the objectives of the WHO Global Patient Safety Challenge: Medication Without Harm launched by WHO in 2017. The campaign calls on stakeholders to prioritize and take early action in key areas associated with significant patient harm due to unsafe medication practices. These include high-risk situations, transitions of care, polypharmacy (concurrent use of multiple medications) and look-alike, sound-alike medications. The campaign will provide a special focus on the implications of the COVID-19 pandemic for medication safety, considering the serious disruption in the provision of health services.
Objectives of World Patient Safety Day 2022:
- RAISE global awareness of the high burden of medication-related harm due to medication errors and unsafe practices, and ADVOCATE urgent action to improve medication safety.
- ENGAGE key stakeholders and partners in the efforts to prevent medication errors and reduce medication-related harm.
- EMPOWER patients and families to be actively involved in the safe use of medication.
- SCALE UP implementation of the WHO Global Patient Safety Challenge: Medication Without Harm.
Join the Action:
WHO is encouraging organisations, individuals and other key stakeholders to participate in World Patient Safety Day 2022 and asks that they:
- share their plans to celebrate.
- pledge their support in achieving Medication Without Harm (Individual/Institutional/Ministerial).
WHO is proposing a wide range of activities on and around 17 September 2022, including national campaigns, policy forums, advocacy and technical events, capacity-building initiatives and, as in previous years, lighting up iconic monuments, landmarks and public places in orange – the signature mark of the campaign!
IAPO’s Campaign – Humor Me Into Medication Safety
To mark World Patient Safety Day (WPSD) 2022 and in support of WHO’s 5 moments for medication safety, the International Alliance of Patients’ Organizations (IAPO) is launching the « Humour me into medication safety » cartoons highlighting the 5 moments for medication safety – a patient engagement tool focusing on the key moments where action by the patient or caregiver can reduce the risk of harm associated with the use of medications. It aims to engage and empower patients to be involved in their own care through collaboration with health professionals.
These cartoons were specially designed to encourage dialogue on social media on how we can all reduce the risk of harm associated with the use of medications. IAPO invites everyone to share them using the hashtag #Humour in #medicationsafety and #WPSD2022. At the end of September the social media post with the best caption will be awarded a prize of USD $500.
Medication Without Harm: Fostering Medication Safety in Hospitals’ webinar
This year, in recognition and support of the WHO’s World Patient Safety Day 2022, the European Health Management Association (EHMA) and the International Alliance of Patient Organisations (IAPO) have joined forces to host a one-hour webinar to raise awareness of medication safety in hospitals.
In this webinar will learn how patient harm from medication can occur if medication is incorrectly stored, prescribed, dispensed, administered or if monitored insufficiently. Attendees will hear from patient representatives and hospitals managers on how harm to patients from medication can be reduced throughempower patients and implementing shared responsibility, innovative tools and cultures of safety.
|Policy-makers and programme managers
|Health care leaders and facility managers
|Patients, families and general public